Correlation Between Relay Therapeutics and Acumen Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Relay Therapeutics and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Relay Therapeutics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Acumen Pharmaceuticals.

Diversification Opportunities for Relay Therapeutics and Acumen Pharmaceuticals

-0.28

Correlation Coefficient

Relay Therapeutics  Acumen Pharmaceuticals

Very good diversification

The 3 months correlation between Relay and Acumen is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between Relay Therapeutics and Acumen Pharmaceuticals

Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the Acumen Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Relay Therapeutics is 1.92 times less risky than Acumen Pharmaceuticals. The stock trades about -0.38 of its potential returns per unit of risk. The Acumen Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  239.00  in Acumen Pharmaceuticals on August 17, 2024 and sell it today you would earn a total of  1.00  from holding Acumen Pharmaceuticals or generate 0.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Relay Therapeutics  vs.  Acumen Pharmaceuticals

Relay Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Relay Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Acumen Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Relay Therapeutics and Acumen Pharmaceuticals

The main advantage of trading using opposite Relay Therapeutics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.

The idea behind Relay Therapeutics and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.